EP
Eversept Partners’s Puma Biotechnology PBYI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $826K | Sell |
240,688
-35,100
| -13% | -$120K | 0.08% | 63 |
|
|
2025
Q1 | $816K | Sell |
275,788
-720,314
| -72% | -$2.13M | 0.08% | 51 |
|
|
2024
Q4 | $3.04M | Sell |
996,102
-297,155
| -23% | -$906K | 0.27% | 46 |
|
|
2024
Q3 | $3.3M | Sell |
1,293,257
-35,197
| -3% | -$89.8K | 0.23% | 47 |
|
|
2024
Q2 | $4.33M | Sell |
1,328,454
-98,043
| -7% | -$320K | 0.3% | 46 |
|
|
2024
Q1 | $7.56M | Sell |
1,426,497
-268,524
| -16% | -$1.42M | 0.5% | 34 |
|
|
2023
Q4 | $7.34M | Buy |
1,695,021
+13,872
| +0.8% | +$60.1K | 0.64% | 29 |
|
|
2023
Q3 | $4.42M | Buy |
1,681,149
+22,954
| +1% | +$60.4K | 0.37% | 41 |
|
|
2023
Q2 | $5.85M | Sell |
1,658,195
-279,893
| -14% | -$988K | 0.49% | 34 |
|
|
2023
Q1 | $5.99M | Buy |
1,938,088
+430,425
| +29% | +$1.33M | 0.42% | 36 |
|
|
2022
Q4 | $6.38M | Buy |
1,507,663
+1,958
| +0.1% | +$8.28K | 0.56% | 35 |
|
|
2022
Q3 | $3.57M | Buy |
1,505,705
+70,628
| +5% | +$167K | 0.31% | 36 |
|
|
2022
Q2 | $4.09M | Buy |
1,435,077
+10,427
| +0.7% | +$29.7K | 0.29% | 42 |
|
|
2022
Q1 | $4.1M | Buy |
1,424,650
+306,752
| +27% | +$883K | 0.32% | 46 |
|
|
2021
Q4 | $3.4M | Buy |
1,117,898
+719,958
| +181% | +$2.19M | 0.22% | 59 |
|
|
2021
Q3 | $2.79M | Buy |
+397,940
| New | +$2.79M | 0.19% | 55 |
|
|
2020
Q2 | – | Sell |
-58,251
| Closed | -$492K | – | 73 |
|
|
2020
Q1 | $492K | Buy |
+58,251
| New | +$492K | 0.12% | 51 |
|
|
2019
Q1 | – | Sell |
-42,301
| Closed | -$861K | – | 58 |
|
|
2018
Q4 | $861K | Buy |
42,301
+20,630
| +95% | +$420K | 0.47% | 37 |
|
|
2018
Q3 | $994K | Sell |
21,671
-2,253
| -9% | -$103K | 0.44% | 33 |
|
|
2018
Q2 | $1.42M | Buy |
23,924
+1,000
| +4% | +$59.2K | 0.65% | 31 |
|
|
2018
Q1 | $1.56M | Sell |
22,924
-31,725
| -58% | -$2.16M | 0.72% | 28 |
|
|
2017
Q4 | $5.4M | Buy |
+54,649
| New | +$5.4M | 3.11% | 12 |
|